Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 28

Results: 12

Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3967, doi. 10.1038/onc.2008.14

By:

Tucker, L. A.;
Zhang, Q.;
Sheppard, G. S.;
Lou, P.;
Jiang, F.;
McKeegan, E.;
Lesniewski, R.;
Davidsen, S. K.;
Bell, R. L.;
Wang, J.

Publication type:

Article

N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3999, doi. 10.1038/onc.2008.15

By:

Kang, J.;
Rychahou, P. G.;
Ishola, T. A.;
Mourot, J. M.;
Evers, B. M.;
Chung, D. H.

Publication type:

Article

The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3977, doi. 10.1038/onc.2008.17

By:

Bahassi, E. M.;
Ovesen, J. L.;
Riesenberg, A. L.;
Bernstein, W. Z.;
Hasty, P. E.;
Stambrook, P. J.

Publication type:

Article

Impaired p53 function leads to centrosome amplification, acquired ERα phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3901, doi. 10.1038/onc.2008.18

By:

D'Assoro, A. B.;
Busby, R.;
Acu, I. D.;
Quatraro, C.;
Reinholz, M. M.;
Farrugia, D. J.;
Schroeder, M. A.;
Allen, C.;
Stivala, F.;
Galanis, E.;
Salisbury, J. L.

Publication type:

Article

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3944, doi. 10.1038/onc.2008.19

By:

Wheeler, D. L.;
Huang, S.;
Kruser, T. J.;
Nechrebecki, M. M.;
Armstrong, E. A.;
Benavente, S.;
Gondi, V.;
Hsu, K.-T.;
Harari, P. M.

Publication type:

Article

Transforming pathways unleashed by a HDAC2 mutation in human cancer.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 4008, doi. 10.1038/onc.2008.31

By:

Ropero, S.;
Ballestar, E.;
Alaminos, M.;
Arango, D.;
Schwartz, S.;
Esteller, M.

Publication type:

Article

Oncogenic role of DDX3 in breast cancer biogenesis.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3912, doi. 10.1038/onc.2008.33

By:

Botlagunta, M.;
Vesuna, F.;
Mironchik, Y.;
Raman, A.;
Lisok, A.;
Winnard, P.;
Mukadam, S.;
Van Diest, P.;
Chen, J. H.;
Farabaugh, P.;
Patel, A. H.;
Raman, V.

Publication type:

Article

Immune escape as a fundamental trait of cancer: focus on IDO.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3889, doi. 10.1038/onc.2008.35

By:

Prendergast, G. C.

Publication type:

Article

Plk1 depletion in nontransformed diploid cells activates the DNA-damage checkpoint.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3935, doi. 10.1038/onc.2008.36

By:

Lei, M.;
Erikson, R. L.

Publication type:

Article

Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3923, doi. 10.1038/onc.2008.38

By:

Tsuchida, R.;
Das, B.;
Yeger, H.;
Koren, G.;
Shibuya, M.;
Thorner, P. S.;
Baruchel, S.;
Malkin, D.

Publication type:

Article

Protein kinase Cɛ confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3957, doi. 10.1038/onc.2008.39

By:

Shankar, E.;
Sivaprasad, U.;
Basu, A.

Publication type:

Article

Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.

Published in:

Oncogene, 2008, v. 27, n. 28, p. 3986, doi. 10.1038/onc.2008.45

By:

Deep, G.;
Oberlies, N. H.;
Kroll, D. J.;
Agarwal, R.

Publication type:

Article